|
|
||||||||
Ann Thorac Surg 2004;78:1409-1417
© 2004 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery and Cardiology, Haut-Lévêque Hospital, Pessac, France
b National Health Institute and Medical Research, Pessac, and University of Bordeaux 2 - Victor Segalen, Bordeaux, Cedex, France
Accepted for publication December 29, 2003.
* Address reprint requests to Dr Barandon, Cardiovascular Surgery Department, Haut-Lévêque Hospital, 33604 Pessac, France
lesbarandon{at}wanadoo.fr
BACKGROUND: Myocardial infarction results in irreversible myocyte loss. In a murine model, we tested the feasibility of a novel repair technique combining bone marrow cell (BMC) transplantation and cardiomyoplasty.
METHODS: Myocardial infarction was induced cryogenically in backcrossed ROSA 26 transgenic x C57BL/6J mice (n = 75). Thirty days later, surviving mice (n = 69) were randomized to sham treatment (rethoracotomy only; n = 11), patch only treatment (n = 29), or patch + BMC treatment (n = 29). Abdominal muscle patches were harvested from donor littermates not expressing the ß-galactosidase reporter gene and sutured on the epicardium directly above the infarct zone. Patch onlytreated mice received uncoated patches. Patch + BMCtreated mice received patches coated with 5 x 106 ß-galactosidase-expressing BMCs embedded in a collagen-rich three-dimensional matrix.
RESULTS: Mortality rate was 52% after muscle patch implantation. Bone marrow cells were able to migrate from muscle patch into the infarct zone, as demonstrated by ß-galactosidase immunostaining, and ultimately constituted 8% of all cells in scar tissue (mean ± standard deviation, 219 ± 111/mm2). Angiogenesis and cell survival in the scar were improved by patch + BMC treatment. Left ventricular geometry and cardiac function were improved by patch treatment, with or without BMC, although the effects were stronger after patch + BMC treatment.
CONCLUSIONS: Epicardial deposition of a BMC-coated muscle patch is a promising approach to restoring cardiac function after myocardial infarction.
This article has been cited by other articles:
![]() |
N. Derval, L. Barandon, P. Dufourcq, L. Leroux, J.-M. D. Lamaziere, D. Daret, T. Couffinhal, and C. Duplaa Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 248 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study Ann. Thorac. Surg., March 1, 2008; 85(3): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siepe, M.-N. Giraud, M. Pavlovic, C. Receputo, F. Beyersdorf, P. Menasche, T. Carrel, and H. T. Tevaearai Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |